EHA Unplugged

[This is a Rerelease. Episode first published on November 22, 2024.]Join us in this podcast episode to get a glimpse of what the future holds in the big field of innovation in hematology. With the help of our host, Dr Gregor Hormann (MLL Munich Leukemia Laboratory, Germany), you will be taken on a journey toward a future that is already here.   
Dr Hormann will discuss the many potentials of AI in hematology and oncology, including the automated integrated diagnostic tools, from morphology to chromosomal banding analysis in a few minutes, new classification algorithms, and innovative large language models (LLMs) assisting physicians in the diagnosis prediction.  
The take-home message? "AI will not replace physicians. However, physicians who use AI will replace those who don't." 

Host: Dr Wilson Lim
Guest: Dr Gregor Hormann

Learn More

What did you think of this podcast? Share your opinions with us in this short feedback survey.
⁠Provide Feedback⁠

Would you like to explore more eLearning or podcasts? Please visit the EHA Campus.
⁠https://ehaedu.org/Campus⁠

Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.
Follow EHA on Instagram: ⁠https://www.instagram.com/EHA_Hematology/⁠
Facebook: ⁠https://e-h-a.link/facebook⁠
LinkedIn: ⁠https://www.linkedin.com/company/eha/⁠
Email us: [email protected]
Subscribe to receive the EHA Educational Updates via ⁠https://eha.news/subscribe⁠

[This is a Rerelease. Episode first published on November 1, 2024.]

Join us for an engaging episode with Dr. Stephen Hibbs from Queen Mary University of London as he discusses the environmental impacts of hematology. Alongside our host Dr. Sarah de Vlieger, they explore how climate change is already affecting hematology, emphasizing that these effects are being felt now rather than in the future.
The conversation highlights how climate change alters aspects of hematology practice, such as the risk of transfusion-transmitted infections due to evolving disease vectors. Dr. Hibbs describes also the surprising link between extreme heat during pregnancy and an increased risk of children developing ALL (acute lymphoblastic leukemia). He further discusses practice-changing initiatives, like using sevoflurane instead of desflurane as an anesthetic to reduce environmental impact, and explains his work on improving the logistics of blood transfusions to lessen their ecological footprint.
Finally, Dr. Hibbs encourages hematologists to focus on actionable steps to minimize their environmental impact, advocating for practical changes in clinical practices and increased awareness of the healthcare sector's contribution to global emissions.
   
Host: Dr Sarah de Vlieger
Guest: Dr Stephen Hibbs

Learn More
What did you think of this podcast? Share your opinions with us in this short feedback survey.
⁠Provide Feedback⁠

Would you like to explore more eLearning or podcasts? Please visit the EHA Campus.
⁠https://ehaedu.org/Campus⁠

Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.
Follow EHA on Instagram: ⁠https://www.instagram.com/EHA_Hematology/⁠
Facebook: ⁠https://e-h-a.link/facebook⁠
LinkedIn: ⁠https://www.linkedin.com/company/eha/⁠
Email us: [email protected]
Subscribe to receive the EHA Educational Updates via ⁠https://eha.news/subscribe⁠

[This is a Rerelease. Episode first published on April 11, 2025.]

Listen to Dr. Jan Moritz Middeke from University Hospital in Dresden as he discusses the future of clinical trials in hematology and the role artificial intelligence (AI) may play in that field.

Dr. Middeke explains how synthetic data is generated and what are the potential benefits and limitations of its use in clinical trials. He also points out the open questions and hurdles that need to be addressed before AI-generated synthetic patients can be included in clinical trial design.

Tune in to hear how Dr. Middeke envisages the role of AI in solving the challenges of clinical trials for rare malignant diseases and how it may accelerate data generation and access to novel therapies.
If you want to know more:
⁠https://www.nature.com/articles/s41746-024-01076-x⁠ 
Host: Isabel Olivera-Martinez, PhD, Medical Writer 
Guest: Dr. Jan Moritz Middeke

Learn More

What did you think of this podcast? Share your opinions with us in this short feedback survey.
⁠https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1⁠

Would you like to explore more eLearning or podcasts? Please visit the EHA Campus.
⁠https://ehaedu.org/Campus⁠

Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.
Follow EHA on Instagram: ⁠https://www.instagram.com/EHA_Hematology/⁠
Facebook: ⁠https://e-h-a.link/facebook⁠
LinkedIn: ⁠https://www.linkedin.com/company/eha/⁠
Email us: [email protected]
Subscribe to receive the EHA Educational Updates via ⁠https://eha.news/subscribe⁠

Join us for this interview with Dr Río-Machín from Autonomous University of Madrid in Spain as she discusses her research on rare subtypes of acute myeloid leukemia (AML), which she conducted thanks to the EHA Junior Research Grant.
Her discovery of transcriptional activator of key leukemia drivers in one of these subtypes may pave way to new therapeutic approaches.
Tune in to hear dr. Río-Machín‘s call for more collaborative research to achieve impactful results for patients in the future.
Host: Isabel Olivera-Martinez, PhD, Medical Writer 
Guest: Dr Ana Río-Machín
Learn More

What did you think of this podcast? Share your opinions with us in this short feedback survey.
https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1

Would you like to explore more eLearning or podcasts? Please visit the EHA Campus.
https://ehaedu.org/Campus

Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.
Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/
Facebook: https://e-h-a.link/facebook
LinkedIn: https://www.linkedin.com/company/eha/
Email us: [email protected]
Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe

Join us for this discussion between Prof Argiris Symeonidis from University of Patras in Greece and Prof Sam Salek from University of Hertfordshire in UK who focus on the role of the hematologist in the diagnosis and management of patients with Gaucher disease.
Prof Symeonidis and Prof Salek are both experts in recognizing and treating this rare lysosomal storage disorder and share their recommendations for hematologists to ensure earlier detection of this disease.
Host: Prof. Sam Salek, University of Hertfordshire, UK
Guest: Prof. Argiris Symeonidis, University of Patras, Rion, Greece
Learn More

What did you think of this podcast? Share your opinions with us in this short feedback survey.
https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1

Would you like to explore more eLearning or podcasts? Please visit the EHA Campus.
https://ehaedu.org/Campus

Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.
Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/
Facebook: https://e-h-a.link/facebook
LinkedIn: https://www.linkedin.com/company/eha/
Email us: [email protected]
Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe